Introduction

In March, the PAI decreased 6.51% month-over-month (MoM) and the S&P 500 decreased 5.09% over the same period. Year-to-date (YTD), the PAI and S&P have dropped 0.11% and 4.63% respectively.

Late in the month, HHS and CMS announced the 18 members that will serve on the newly created Federal Healthcare Advisory Committee (HAC). “These members bring deep expertise across care delivery, financing, innovation, and patient engagement. Their insights will help us advance higher-quality care, reduce administrative burden, and strengthen the sustainability of our programs, while supporting efforts to transform our healthcare system and restore a stronger focus on patients,” said CMS Administrator Dr. Mehmet Oz.

This committee will provide non-binding recommendations to HHS Secretary Robert F. Kennedy and CMS Administrator Dr. Mehmet Oz on how to finance healthcare through Medicare, Medicaid, the Children’s Health Insurance Program, and the Health Insurance Marketplace. The newly selected members have diverse experience and backgrounds across numerous sectors and will serve two-year terms on the HAC.

In late February, Enhabit announced that it would be acquired by the private equity firm, Kinderhook Industries LLC, for $1.1 billion in an all-cash transaction. The deal is expected to close in the second quarter of 2026, at which point Enhabit will be de-listed from the New York Stock Exchange.

“Thanks to its exceptional care teams and strong leadership, Enhabit has built a reputation for excellence across the healthcare industry. As a supportive partner, our role is to grow and foster the great work they’re already doing and to help remove barriers so their teams can stay focused on patients,” said Matt Bubis, Managing Director at Kinderhook.

“While public market performance softened in March, we continue to see active buyer interest across the home-based care sector,” said Ben Bogan, partner and managing director at Stoneridge Partners. “While it will be interesting to see how the newly appointed Healthcare Advisory Committee will impact Medicare and Medicaid policy through the remainder of the year, we’re seeing that well-positioned home health and hospice providers are continuing to attract interest from both strategic and financial buyers.”

Post Acute Care Index (PAI)

In March, Pennant’s stock price decreased 9.58% and was up 8.28% YTD. In its fourth quarter and FY 2025 Results, the Pennant Group announced total revenue of $289.3 million representing a 53.2% increase from the prior-year quarter. In addition, Q4 Adjusted EBITDA was $22.4 million, a 62.5% increase over the same period in 2024.

“2025 was a year of record-breaking performance and growth for Pennant,” said CEO Brent Guerisoli. “Our operational flywheel continues to gain momentum, even in the midst of accelerative expansion. Our growth wasn’t only significant in its magnitude—it was strategic, high-quality investment.” Late last year, Pennant acquired 54 home health, hospice, and personal care locations divested from Amedisys and UnitedHealth for $146.5 million.

Brookdale’s stock price decreased 10.59% in March but was up 26.78% YTD. In the company’s full-year 2025 results, it announced a Q4 net loss of $40 million compared to a net loss of $83.9 million in Q4 2024. The company’s Q4 Adjusted EBITDA was $105.6 million, a 7.1% increase over the same period in 2024. According to CFO Nick Stengle, “Brookdale’s fourth quarter results continued the positive momentum displayed throughout 2025, as we position Brookdale to capitalize on increasing industry demand in a suppressed supply growth environment. We are pleased with the results we delivered as we focus on operational excellence and delivering shareholder value.”

Aveanna’s stock decreased 12.5% during the month and is down 21.18% YTD. Despite the dip, the company announced strong performance in its Q4 2025 financial results. This included Q4 revenue of $662.5 million, a 27.4% increase from the prior-year period, and Q4 Adjusted EBITDA of $85.0 million, a 54% increase over the prior-year period. “2025 was a monumental year for Aveanna,” said CFO Matt Buckhalter. “Our team delivered exceptional performance across the business, generating annual revenue growth of 20.2% and Adjusted EBITDA growth of 74.8%. These results reflect the strength of our clinical model, the dedication of our caregivers, and the disciplined execution of our strategy across each of our segments.”

Conclusion

In March, public market performance declined across both the PAI and broader indices, despite continued strong operating results reported by publicly traded home-based care providers. While the formation of the Healthcare Advisory Committee introduces some uncertainty around future Medicare and Medicaid policy, it also reflects an ongoing focus on improving care delivery and reimbursement structures. As the industry moves further into 2026, buyer interest remains active, with strategic and financial groups continuing to evaluate new opportunities and advance transactions already underway.

Q: Are deal structures changing in today’s market?

A: Deal structures are not necessarily changing in today’s market, particularly for larger, high-quality assets attracting top-tier strategic buyers. For other opportunities, we are seeing more creative use of earnouts and structured consideration in certain situations, but every transaction remains unique. In processes that attract strong interest from multiple buyers, sellers may receive a range of offers with different terms and structures. As always, running a competitive process remains critical to maximizing both price and deal terms.

This “Ask Stoneridge” segment will be a recurring feature in our monthly updates. We encourage readers to submit questions related to the M&A process, valuation, or current market conditions in home-based care. Our team will select questions to address in future publications. Please send inquiries to [email protected] or contact us through our website.

Quote of the Month

“Hospice care is an invaluable part of the Medicare program, with evidence demonstrating that it is the preferred choice by patients and families when appropriate. While a 2.4% payment increase is a step in the right direction, more must be done to ensure that high-quality providers have the resources they need to operate in this demanding environment.”

– Jennifer Sheets, CEO of the Alliance for Care at Home

Read the Full Article Here: National Alliance for Care at Home Responds to the FY 2027 Hospice Proposed Rule

Stoneridge In the News:

The Pre-Sale Due Diligence Checklist for Healthcare Owners (2026 Edition) Read the Full Article Here Blog written by Partner & Managing Director Ben Bogan.

See It To Believe It!

The Stoneridge Partners Post-Acute Care Index is updated monthly and measures the performance of these six publicly traded post-acute care companies, all listed on the NASDAQ:

  • Addus (ADUS)
  • Aveanna (AVAH)
  • BrightSpring (BTSG)
  • Brookdale Senior Living Inc. (BKD)
  • Enhabit (EHAB)
  • The Pennant Group, Inc. (PNTG)

Here are the results of the Post-Acute stock prices for the past two years:

Enterprise Value (EV)

Enterprise Value (EV), aka Selling Price, as Percent of Revenue

The above calculations are based on the selling price being defined as Enterprise Value (EV), with data provided by Yahoo Finance. Enterprise value is defined as market cap plus debt, minority interest, and preferred shares, minus total cash and cash equivalents. EBITDA is calculated using a methodology that may differ from that used by a company for its reporting. (Home Health Index March 2026 | Stoneridge Partners)

Recent Transactions From Around The Country

  • Residential Home Health and Hospice acquired Covenant Home Health
  • HouseWorks Holdings acquired A Caring Experience
  • MedArrive acquired Inbound Health assets
  • Sevita acquired ResCare Community Living
  • Canyon Home Care & Hospice acquired Columbine Poudre Home Care

SOLD by Stoneridge!!!

  • Stoneridge Partners is proud to announce the successful sale of a Kentucky I/DD agency.

View Stoneridge closed transactions on our Website.

Exclusively Listed For Sale By Stoneridge Partners.

Do you know of any acquisitions that have taken place? We are interested in your comments. Contact us at Stoneridge Partners.

Multistate DME and pharmacy platform opportunity.  $48M+ in revenue.  $19M EBITDA.  Comprehensive, audited financial statements.  Seasoned executive leadership team dedicated to remaining post-transaction.

 Other /  Multi-State

Behavioral health therapy practice.  $3.8M in LTM revenue with over 20% margins.  20 year history in the state with a broad base of payors.  CARF...

 Behavioral Health /  Georgia

Non-skilled home care and adult day services.  $3.3M in revenue.  Certificate of Need.  75% Medicaid.

 Home Care /  Kentucky

Mental health counseling & therapy center.  $1M in revenue.  Long-established practice with excellent reputation.

 Behavioral Health /  Texas

Home care company.  $7M in revenue.  20%+ AEBITDA.  90%+ non-medical.  Primarily auto-injury related/long-term clients.  Payor sources are mainly auto insurers.

 Home Care /  Michigan

Fully licensed and accredited SUD clinic.  $3.5M in annual revenue.  Operating continuously for over 40 years.  2 locations with residential and outpatient services.

 Behavioral Health /  Ohio

Home care agency.  $16M+ revenue.  100% Medicaid-reimbursed.  Approx. 50% skilled/50% non-medical.  Medicare-certified.

 Home Care /  Ohio

Home health agency.  $3M in revenue.  75% Medicaid, but Medicare Certification as well.  Long history of success.

 Home Health /  Colorado

4 adult care homes in Eastern NC.  99 beds licensed under adult care homes.  CON status on this license category in NC.  Some renovations needed,...

 Other /  North Carolina

Non-skilled home care agency.  $3.7M in revenue.  100% Medicaid.  2 offices in major metro locations.

 Home Care /  Texas

Medicaid home health provider in major Texas MSA.  $1.9M of 2025 annualized revenue.  20-year history in the community.  Quality staff in place.

 Home Health /  Texas

Multi-State Mental Health Services Provider.  $2.75M in revenue.  Efficient cost structure and consistent earnings.  Proven scalable platform.

 Behavioral Health /  Mid-Atlantic

Fully licensed and accredited behavioral health clinic.  Licensed for outpatient substance abuse and mental health therapy.  Other license categories are easy to add.  Credentialed with...

 Behavioral Health /  New Jersey

Medicaid wavier provider.  Serving six counties in south central PA for 25+ years.  Licensed to provide CHC, Attendant Care ACT 150, and OBRA Waivers.  $262k...

 Other /  Pennsylvania

Medicare-certified home health agency.  $3.2M in LTM revenue.  Medicaid programs comprise nearly 65% of the revenue.  VA and private insurance.  4 locations serving 21 counties.

 Home Health /  Iowa

Hospice.  160+ ADC and growing.  Multiple locations.  No CAP issues.

 Hospice /  New Mexico

Independent home health provider.  $16.8M LTM in revenue with 13.1% EBITDA.  Organic growth of 16.7% over the last 3 years.  44% traditional Medicare, 49% Medicare...

 Home Health /  Northeast

Home care agency specializing in Medicaid family-supported services.  $10M in revenue/$3M EBITDA.  10-year history.  Locally acclaimed.

 Home Care /  Midwest

Home health and home care agency providing care to Medicare, Medicaid LTC Waiver, Pediatric and Advanced Neurological patients.  $4.5M in revenue.  AEBITDA of over 12%. ...

 Home Health /  Florida

Hospice and IPU.  $5.5M in revenue.  Deep community ties in a major MSA.  Highly dedicated and trained staff.

 Hospice /  Indiana

Home care company.  $6M in revenue.  Non-medical.  Medicaid.  Family Caregivers.

 Home Care /  Pennsylvania / Popular

Home health & hospice.  $10M in revenue.  Great referral sources.  Well-established.  On HCHB.

 Hospice /  Midwest

Home care company.  $7M in revenue.  Private pay, non-medical.  Accredited.

 Home Care /  Southeast

Medicare and Medicaid-certified home health agency.  Approx. $400k in revenue.  Central Arizona.

 Home Health /  Arizona

Professionally operated home health agency.  $1.8M in revenue.  20% EBITDA margins.  20+ years in the Houston market.

 Home Health /  Texas / Popular

Home care franchise.  $1.3M in revenue.  13+ years in business.  Large territory with growth potential.

 Home Care /  Tennessee

Outpatient behavioral health provider.  $4.5M+ in LTM revenue.  Year-over-year revenue growth.  Growth/expansion opportunities with a new location and new services.  Licensed to serve a total...

 Behavioral Health /  Pennsylvania / Popular

Nurse registry.  $7M in revenue.  100% private pay.  Primarily non-medical home care.  District 9.

 Home Care /  Florida / Popular

Long-established Medicare/Medicaid home health agency with multiple locations.  $7.3M in revenue.  Good payor mix.  On Homecare Homebase.

 Home Health /  Ohio / Popular

Home health agency in 2 states, one a CON.  $3M+ in revenue.  Good payor mix.  5-star patient survey rating.

 Home Health /  Multi-State / Popular

Behavioral health provider.  $5.5M+ revenue with solid EBITDA margins.  Leading edge service provider and with proprietary state contracts.  Unique combination of service options and contracts...

 Behavioral Health /  Maryland / Popular

Medicaid/Medicare home health & home care company.  $2.4M in revenue.  Well-established.  Stable revenue.  Profitable year-over-year.

 Home Health /  Connecticut / Popular

Designer/Distributor of innovative, therapeutic, health and wellness personal products.  $1.5M+ in revenue.  Launched in the US and UK, now launching into the EU.  Nearly 7,000...

 Other /  New York / Popular

Homecare agency.  $6.5M+ in revenue.  Located on Long Island.  Blend of Private Duty & Medicaid patients.

 Home Care /  New York / Popular

Maricopa County hospice.  40+ ADC.  CHAP accredited.  No CAP or regulatory issues.

 Hospice /  Arizona / Popular

Growing ABA (Autism) therapy clinic established in 2020.  $1.6M in revenue.  Market demand heavily outweighs supply in the area for ABA therapy.

 I/DD /  Virginia / Popular

Northeast Oklahoma home health company.  $1.7M of revenue and profitable.  95% traditional Medicare.  Long history in the area.

 Home Health /  Oklahoma / Popular

Special education and tutorial provider with limited access contracts.  $3M in revenue.  Strong relationships with county school programs.  Long history in the community, close to...

 I/DD /  New York / Popular

Medicare-certified home health agency.  $1.25M in revenue.  AHCA accredited.  Broward County (Region 10)

 Home Health /  Florida / Popular

Medicare-certified home health agency.  Region 7, including sought-after Orange county (Orlando).  Minimal census.

 Home Health /  Florida / Popular

Phoenix-area hospice.  35+ ADC.  Accredited.

 Hospice /  Arizona / Popular

$5M in revenue.  Located in Northern/Richmond VA.  Health system-owned Medicare home health.  Growing organization.

 Home Health / Popular

Hospice.  45+ ADC.  Rio Grande Valley.  No CAP or regulatory issues.

 Hospice /  Texas / Popular

Home Health Index March 2026 | Stoneridge Partners

From Ben Bogan, Publisher of “Home Health Index.” Ben can be reached at [email protected] or (239) 561-0826, and toll-free at 800-218-3944. Previous editions of this monthly newsletter can be searched for at the bottom of the home page of the Home Health Index.

Ben B

Ben Bogan, J.D., Partner and Managing Director at Stoneridge Partners, has been a leading figure in healthcare M&A since 2014, specializing in home health, home care, and hospice transactions. With over 80 successful closed deals, Ben’s experience and expertise have set him apart as a skilled and invaluable intermediary in the industry.
 
With a law degree from Albany Law School, a BSBA in Economics from the University of Florida, and his background as a former Assistant District Attorney and Assistant District Counsel for the U.S. Army Corps of Engineers, Ben combines his legal background and M&A expertise to deliver exceptional results in every transaction. Available to his clients 24/7, Ben builds strong relationships with his clients and has garnered rave reviews.

For more information, please contact Ben directly at 520-991-4653 or [email protected]. All communications are confidential.